載入...
Post Hoc Health‐Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies
BACKGROUND: The phase III PROSELICA (NCT01308580) and FIRSTANA (NCT01308567) trials investigated taxane chemotherapy among men with postdocetaxel metastatic, castration‐resistant prostate cancer (mCRPC) or chemotherapy‐naïve mCRPC, respectively. We present a post hoc analysis of patient‐reported hea...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265338/ https://ncbi.nlm.nih.gov/pubmed/33904646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13803 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|